MERSCOPE, the first high multiplexing, high resolution in situ platform to combine single-cell and spatial genomicsLearn More
Meet the Vizgen Team: Joanna JoyRead More
First Platform for Massively Multiplexed Single-Cell In Situ Spatial Genomics Now Broadly Available to U.S. MarketRead More
Meet the Vizgen Team: Aayushi MaheshwariRead More
The Scientist 2021 Top 10 InnovationsRead More
The next generation of genomics is here...
Vizgen is dedicated to pioneering the next generation of genomics, providing tools that demonstrate the possibilities of in situ single cell spatial genomics, setting the standard for the spatial genomics field. These tools are enabling researchers to gain new insight into the biological systems that govern human health and disease with spatial context.
Vizgen’s MERSCOPE Platform is powered by the proprietary MERFISH (Multiplexed Error-Robust Fluorescence in situ Hybridization) technology, a quantitative and genome-scale multiplexed imaging technique for identifying nucleic acids in their native tissue environment with resolution scaling from subcellular to tissue scale.